Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Gilead Sciences (NQ:GILD)

114.55 -3.31 (-2.81%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,468,078
Open 117.49
Bid (Size) 115.00 (1)
Ask (Size) 115.98 (2)
Prev. Close 117.86
Today's Range 114.17 - 117.63
52wk Range 81.57 - 121.83
Shares Outstanding 1,253,809,440
Dividend Yield 2.76%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
GILEAD SCIENCES INC (NASDAQ:GILD): A Prime Value Investing Candidate with Strong Fundamentals
Gilead Sciences (GILD) is a strong value investing candidate, trading at a significant discount with high profitability, solid financial health, and positive growth prospects. 
Via Chartmill
SLB, Apple, Nvidia, Merck, Gilead Sciences: What Sparked Heavy After-Hours Trading In These 5 Stocks?
Via Stocktwits

Performance

YTD
+24.7%
+24.7%
1 Month
-4.7%
-4.7%
3 Month
+4.2%
+4.2%
6 Month
+2.8%
+2.8%
1 Year
+37.7%
+37.7%

More News

Read More
Tariffs Cast a Long Shadow: Consumer Prices Soar Across Essential Goods
Via MarketMinute
Topics Economy Government World Trade
Why Is Novo Nordisk’s Stock Rising Premarket Today?
Via Stocktwits
Xilio Stock Jumps 8% On Cancer Drug Data; Gilead Boost Extends Cash Runway Into 2027 — Retail Says Stock Undervalued
Via Stocktwits
Cooling Wages Cast a Shadow: Economic Recovery at Risk as Consumer Spending Slows
Via MarketMinute
Topics Credit Cards Economy Supply Chain
InvestorNewsBreaks – NanoViricides (NYSE American: NNVC) to Present at LSX World Congress 2025
Via Investor Brand Network
Topics Intellectual Property
Wolfspeed, Nvidia, Gilead, SLBM, Corning: What Sparked Heavy After-Hours Trading In These 5 Stocks?
Via Stocktwits
Topics Artificial Intelligence Bankruptcy Economy
Global Economic Slowdown and Escalating Tariffs: A Looming Threat to Market Growth
Via MarketMinute
Topics Economy Supply Chain World Trade
2024 R&D Spending and Intensity Benchmarks
Via PRLog
Topics Supply Chain
Gilead Announces Partnership With PEPFAR to Deliver Twice-Yearly Lenacapavir for HIV Prevention for up to Two Million People in Primarily Low- and Lower-Middle-Income Countries
From Gilead Sciences, Inc.
Via Business Wire
Gilead Sciences Launches Choose U™ Campaign Spotlighting the Inspiring Experiences of People Living with HIV
From Gilead Sciences, Inc.
Via Business Wire
Gilead Sciences Breaks Ground on New Manufacturing Hub, a Cornerstone of Its U.S. Growth and Innovation Strategy
From Gilead Sciences, Inc.
Via Business Wire
1 Healthcare Stock to Consider Right Now and 2 We Question
Via StockStory
Topics Stocks
Beating The September Curse–These 10 Stocks Shine While The S&P 500 Stumbles
Via Benzinga
Topics Stocks
Veeva Makes A Bearish Move On One Pockmark In Its Quarterly Report
Via Investor's Business Daily
Eli Lilly Scores Another Weight-Loss Win; Viking, Novo Stocks Slump
Via Investor's Business Daily
Gilead Sciences' 99.9% Effective HIV Treatment Notches Another Win
Via Investor's Business Daily
European Commission Authorizes Twice-Yearly Yeytuo® (Lenacapavir) for HIV Prevention
From Gilead Sciences, Inc.
Via Business Wire
Options Corner: Why The Market Could Be Prescribing A Bull Call Spread For Gilead Sciences
Via Benzinga
Here's How Much You Would Have Made Owning Gilead Sciences Stock In The Last 20 Years
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Drug Tariffs Finally Land. Why Pharma Stocks Are Breathing Easy.
Via Investor's Business Daily
Topics ETFs Government Intellectual Property
Market Monitor News August 22 BMO - Coty Crumbles, Powell Looms: Wall Street Cautious Amid Mixed Signals
Via Chartmill
Topics Economy
Gildea's Kite Pharma Just Acquired Interius—$350 Million Move Shakes Up Cancer Therapy
Via Benzinga

Frequently Asked Questions

Is Gilead Sciences publicly traded?
Yes, Gilead Sciences is publicly traded.
What exchange does Gilead Sciences trade on?
Gilead Sciences trades on the Nasdaq Stock Market
What is the ticker symbol for Gilead Sciences?
The ticker symbol for Gilead Sciences is GILD on the Nasdaq Stock Market
What is the current price of Gilead Sciences?
The current price of Gilead Sciences is 114.55
When was Gilead Sciences last traded?
The last trade of Gilead Sciences was at 09/12/25 04:00 PM ET
What is the market capitalization of Gilead Sciences?
The market capitalization of Gilead Sciences is 143.62B
How many shares of Gilead Sciences are outstanding?
Gilead Sciences has 144B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.